Industry comparison
Biotechnology
CodeNameLastChange(%)descendingP/EYield (%)P/E Range
EQEquillium0.71+81.59%---- 
FDMT4D Molecular Therapeutics6.42+42.67%---- 
SNSESensei Biotherapeutics Inc10.325+38.03%---- 
IMABI-MAB2.62+30.35%---- 
LIXTLixte Biotechnology Holdings4.87+22.67%---- 
PSTVPlus Therapeutics0.585+21.12%---- 
SABSSAB Biotherapeutics2.23+18.62%---- 
APLMWApollomics0.0328+18.41%---- 
CLLSCellectis SA2.95+17.53%---- 
CVMCel-Sci Corp9.45+15.53%---- 
RLYBRallybio Corp0.535+15.05%---- 
OKYOOKYO Pharma Limited3.1+14.81%---- 
ABVCABVC BioPharma2.75+14.58%---- 
CGTXCognition Therapeutics0.6674+13.93%---- 
RADXRadiopharm Theranostics Limited5.35+13.83%---- 
AUPHAurinia Pharmaceuticals10.49+13.47%34.24--PE
CRDFCardiff Oncology2.64+11.39%---- 
KALAKala BIO7.5+10.78%---- 
SRZNSurrozen11+10.00%---- 
PLRXPliant Therapeutics1.58+8.22%---- 
Smiley faceQuotes are at least 15-min delayed:2025/08/02 19:06 EDT
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.